OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Webinar on Cancer Biomarker
Cancer Biomarker Webinar

OriGene TissueScan in recent publications
Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis J. Natl. Cancer Inst. Apr 2015 [Tissues]

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

RNA (5 µg); Breast; Adenocarcinoma of breast, ductal

Specifications Related Products Research Agreement FAQs
Catalog No. Description Price Shipping
CR562689 RNA (5 µg); Breast; Adenocarcinoma of breast, ductal $ 289 3 days
<< Back to Search Result   Add to Shopping Cart
Disease StateCancer
Diagnosis CategoryBreast Cancer
TissueBreast
Case IDCU0000001243
Prep5
Vial IDRN0000150A
Frozen Sample IDFR00004D97
Tissue of OriginBreast
Site of FindingBreast
AppearanceTumor
Sample Diagnosis (from Pathology Verification)Adenocarcinoma of breast, ductal
Normal0%
Lesional0%
Tumor50%
Tumor Hypo/Acellular Stroma50%
Tumor Hypercellular Stroma0%
Necrosis0%
Pathology Verification notes from H&E review
Bioanalyzer Ratio (28S/18S)1.26
CASE Diagnosis (from medical center path report)Adenocarcinoma of breast, ductal
Age56
GenderFemale
Race
Tumor GradeNSABP Grade: Nuclear 3 of 3 & Histologic 3 of 3
Minimum Stage GroupingIIIC
T (Extent of Primary Tumor) T2
N (Lymph node metastasis) N3a
M (Distant metastasis)MX
Diagnostic Test Results

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title